192 related articles for article (PubMed ID: 32553721)
1. Cautious interpretation of antiphospholipid antibodies in COVID-19.
Mehta S; Bhandari S; Mehta S
Clin Chim Acta; 2020 Oct; 509():166. PubMed ID: 32553721
[No Abstract] [Full Text] [Related]
2. Are antiphospholipid antibodies associated with thrombotic complications in critically ill COVID-19 patients?
Siguret V; Voicu S; Neuwirth M; Delrue M; Gayat E; Stépanian A; Mégarbane B
Thromb Res; 2020 Nov; 195():74-76. PubMed ID: 32663703
[TBL] [Abstract][Full Text] [Related]
3. Researchers Home in on COVID-19 Severity Biomarkers.
Abbasi J
JAMA; 2020 Jul; 324(2):128. PubMed ID: 32662846
[No Abstract] [Full Text] [Related]
4. Interleukin-6 as a potential biomarker of COVID-19 progression.
Ulhaq ZS; Soraya GV
Med Mal Infect; 2020 Jun; 50(4):382-383. PubMed ID: 32259560
[No Abstract] [Full Text] [Related]
5. Emerging key laboratory tests for patients with COVID-19.
Kavsak PA; de Wit K; Worster A
Clin Biochem; 2020 Jul; 81():13-14. PubMed ID: 32360478
[No Abstract] [Full Text] [Related]
6. SARS-CoV-2-related atypical thyroiditis.
Muller I; Cannavaro D; Dazzi D; Covelli D; Mantovani G; Muscatello A; Ferrante E; Orsi E; Resi V; Longari V; Cuzzocrea M; Bandera A; Lazzaroni E; Dolci A; Ceriotti F; Re TE; Gori A; Arosio M; Salvi M
Lancet Diabetes Endocrinol; 2020 Sep; 8(9):739-741. PubMed ID: 32738929
[No Abstract] [Full Text] [Related]
7. Eosinopenia could be a relevant prognostic biomarker in patients with coronavirus disease 2019.
Perlini S; Ciprandi G; Castagnoli R; Licari A; Marseglia GL
Allergy Asthma Proc; 2020 Nov; 41(6):e80-e82. PubMed ID: 33109314
[No Abstract] [Full Text] [Related]
8. Two consecutive myocardial tissue insults for inpatients with COVID-19.
Su M; Peng J; Wu M; Deng W; Yang Y; Peng YG
Crit Care; 2020 May; 24(1):259. PubMed ID: 32456648
[No Abstract] [Full Text] [Related]
9. Covid-19 antibody tests: a briefing.
Baraniuk C
BMJ; 2020 Jun; 369():m2284. PubMed ID: 32580937
[No Abstract] [Full Text] [Related]
10. Profile of natural anticoagulant, coagulant factor and anti-phospholipid antibody in critically ill COVID-19 patients.
Zhang Y; Cao W; Jiang W; Xiao M; Li Y; Tang N; Liu Z; Yan X; Zhao Y; Li T; Zhu T
J Thromb Thrombolysis; 2020 Oct; 50(3):580-586. PubMed ID: 32648093
[TBL] [Abstract][Full Text] [Related]
11. High Incidence of False-Positive Results in Patients with Acute Infections Other than COVID-19 by the Liaison SARS-CoV-2 Commercial Chemiluminescent Microparticle Immunoassay for Detection of IgG Anti-SARS-CoV-2 Antibodies.
Boukli N; Le Mene M; Schnuriger A; Cuervo NS; Laroche C; Morand-Joubert L; Gozlan J
J Clin Microbiol; 2020 Oct; 58(11):. PubMed ID: 32848041
[No Abstract] [Full Text] [Related]
12. Lower detection rates of SARS-COV2 antibodies in cancer patients versus health care workers after symptomatic COVID-19.
Solodky ML; Galvez C; Russias B; Detourbet P; N'Guyen-Bonin V; Herr AL; Zrounba P; Blay JY
Ann Oncol; 2020 Aug; 31(8):1087-1088. PubMed ID: 32360743
[No Abstract] [Full Text] [Related]
13. Labs scramble to produce new coronavirus diagnostics.
Cohen J; Kupferschmidt K
Science; 2020 Feb; 367(6479):727. PubMed ID: 32054740
[No Abstract] [Full Text] [Related]
14. Cardiac Troponin I Is an Independent Predictor for Mortality in Hospitalized Patients With COVID-19.
Nie SF; Yu M; Xie T; Yang F; Wang HB; Wang ZH; Li M; Gao XL; Lv BJ; Wang SJ; Zhang XB; He SL; Qiu ZH; Liao YH; Zhou ZH; Cheng X
Circulation; 2020 Aug; 142(6):608-610. PubMed ID: 32539541
[No Abstract] [Full Text] [Related]
15. Severe COVID-19 infection associated with endothelial activation.
Escher R; Breakey N; Lämmle B
Thromb Res; 2020 Jun; 190():62. PubMed ID: 32305740
[No Abstract] [Full Text] [Related]
16. Insights into pediatric multi-system inflammatory syndrome and COVID-19.
Bar-Or D; Rael LT; Brody EN
Clin Chim Acta; 2020 Nov; 510():121-122. PubMed ID: 32673668
[No Abstract] [Full Text] [Related]
17. Hematological changes in Covid-19 infections.
Duarte FB; Lemes RPG; Duarte IA; Duarte BA; Duarte JVA
Rev Assoc Med Bras (1992); 2020 May; 66(2):99. PubMed ID: 32428139
[No Abstract] [Full Text] [Related]
18. Recurrence of immune thrombocytopenia at the time of SARS-CoV-2 infection.
Merli M; Ageno W; Sessa F; Salvini M; Caramazza D; Mora B; Rossi A; Rovelli C; Passamonti F; Grossi P
Ann Hematol; 2020 Aug; 99(8):1951-1952. PubMed ID: 32529284
[No Abstract] [Full Text] [Related]
19. Distinct features of SARS-CoV-2-specific IgA response in COVID-19 patients.
Yu HQ; Sun BQ; Fang ZF; Zhao JC; Liu XY; Li YM; Sun XZ; Liang HF; Zhong B; Huang ZF; Zheng PY; Tian LF; Qu HQ; Liu DC; Wang EY; Xiao XJ; Li SY; Ye F; Guan L; Hu DS; Hakonarson H; Liu ZG; Zhong NS
Eur Respir J; 2020 Aug; 56(2):. PubMed ID: 32398307
[TBL] [Abstract][Full Text] [Related]
20. Laboratory Biomarkers Predicting COVID-19 Severity in the Emergency Room.
Assandri R; Buscarini E; Canetta C; Scartabellati A; Viganò G; Montanelli A
Arch Med Res; 2020 Aug; 51(6):598-599. PubMed ID: 32471703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
